首页 > 最新文献

Surgery in practice and science最新文献

英文 中文
Single-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan 单个外科医生的开放性膀胱根治术治疗肌肉浸润性膀胱癌的结果:来自阿塞拜疆三级中心的经验
IF 0.6 Q4 SURGERY Pub Date : 2025-07-03 DOI: 10.1016/j.sipas.2025.100296
Rashad Sholan , Rufat Aliyev , Seymur Karimov , Jamal Musayev , Anar Almazkhanli , Rahman Ismayilov

Objective

Radical cystectomy is the standard treatment for muscle-invasive bladder cancer (MIBC). This study presents the first analysis of open radical cystectomy (ORC) outcomes in Azerbaijan, where robotic surgery is unavailable.

Methods

We retrospectively analyzed 106 patients with non-metastatic MIBC who underwent ORC with bilateral pelvic lymph node dissection and Bricker ileal conduit reconstruction, performed by a single surgeon between 2014 and 2024. Demographic data, comorbidities, operative metrics (duration, blood loss), complications, length of stay, and follow-up data were analyzed.

Results

The cohort's mean age was 64.2 years (72.6 % male), with common comorbidities including hypertension (33 %), diabetes (33 %), and coronary artery disease (24.5 %). The median operative time was 300 min and blood loss was 450 mL. Postoperative complications occurred in 9.4 %, primarily urinary tract infections. No intraoperative complications or in-hospital mortalities occurred. Longer hospital stays were associated with advanced age (p < 0.001), higher body mass index (p = 0.042), longer operative time (p < 0.001), and increased blood loss (p = 0.008). Of all patients, 58.5 % were followed for a median of 71.3 months with no observed recurrences. There were three non-cancer related deaths.

Conclusion

This initial report from Azerbaijan demonstrates acceptable perioperative outcomes for ORC in MIBC, despite the absence of robotic surgery. Our findings emphasize optimizing surgical efficiency, comorbidity management, and strengthening follow-up to enhance patient outcomes in resource-limited settings.
目的:根治性膀胱切除术是肌浸润性膀胱癌(MIBC)的标准治疗方法。本研究首次分析了阿塞拜疆开放性根治性膀胱切除术(ORC)的结果,在阿塞拜疆,机器人手术是不可用的。方法回顾性分析2014年至2024年间106例接受ORC合并双侧盆腔淋巴结清扫和Bricker回肠导管重建的非转移性MIBC患者。分析了人口统计数据、合并症、手术指标(持续时间、出血量)、并发症、住院时间和随访数据。结果该队列的平均年龄为64.2岁(男性占72.6%),常见合并症包括高血压(33%)、糖尿病(33%)和冠状动脉疾病(24.5%)。中位手术时间为300分钟,出血量为450毫升。术后并发症发生率为9.4%,主要为尿路感染。无术中并发症及院内死亡。住院时间较长与高龄相关(p <;0.001),较高的体重指数(p = 0.042),较长的手术时间(p <;0.001),出血量增加(p = 0.008)。在所有患者中,58.5%的患者随访时间中位数为71.3个月,未观察到复发。有3例与癌症无关的死亡。来自阿塞拜疆的初步报告表明,尽管没有机器人手术,但MIBC中ORC的围手术期结果是可接受的。我们的研究结果强调在资源有限的情况下优化手术效率、合并症管理和加强随访以提高患者的预后。
{"title":"Single-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan","authors":"Rashad Sholan ,&nbsp;Rufat Aliyev ,&nbsp;Seymur Karimov ,&nbsp;Jamal Musayev ,&nbsp;Anar Almazkhanli ,&nbsp;Rahman Ismayilov","doi":"10.1016/j.sipas.2025.100296","DOIUrl":"10.1016/j.sipas.2025.100296","url":null,"abstract":"<div><h3>Objective</h3><div>Radical cystectomy is the standard treatment for muscle-invasive bladder cancer (MIBC). This study presents the first analysis of open radical cystectomy (ORC) outcomes in Azerbaijan, where robotic surgery is unavailable.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed 106 patients with non-metastatic MIBC who underwent ORC with bilateral pelvic lymph node dissection and Bricker ileal conduit reconstruction, performed by a single surgeon between 2014 and 2024. Demographic data, comorbidities, operative metrics (duration, blood loss), complications, length of stay, and follow-up data were analyzed.</div></div><div><h3>Results</h3><div>The cohort's mean age was 64.2 years (72.6 % male), with common comorbidities including hypertension (33 %), diabetes (33 %), and coronary artery disease (24.5 %). The median operative time was 300 min and blood loss was 450 mL. Postoperative complications occurred in 9.4 %, primarily urinary tract infections. No intraoperative complications or in-hospital mortalities occurred. Longer hospital stays were associated with advanced age (<em>p</em> &lt; 0.001), higher body mass index (<em>p</em> = 0.042), longer operative time (<em>p</em> &lt; 0.001), and increased blood loss (<em>p</em> = 0.008). Of all patients, 58.5 % were followed for a median of 71.3 months with no observed recurrences. There were three non-cancer related deaths.</div></div><div><h3>Conclusion</h3><div>This initial report from Azerbaijan demonstrates acceptable perioperative outcomes for ORC in MIBC, despite the absence of robotic surgery. Our findings emphasize optimizing surgical efficiency, comorbidity management, and strengthening follow-up to enhance patient outcomes in resource-limited settings.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100296"},"PeriodicalIF":0.6,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144588485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency general surgery: The prevalence of non-operative consultations and importance of a registry 急诊普通外科:非手术咨询的流行和登记的重要性
IF 0.6 Q4 SURGERY Pub Date : 2025-07-02 DOI: 10.1016/j.sipas.2025.100295
Nisha Narula , Shanen M. Mulles , Aziz M. Merchant , Kenechi Onwubalili , Lauren Cue , Michele Fiorentino , Nina Awan , Joseph B. Oliver , Dustin Cummings , Michael E. Shapiro , Anne C. Mosenthal , David H. Livingston , Nina E. Glass

Introduction

An emergency general surgery (EGS) service is a crucial component of care in a hospital. Current reviews of EGS focus on procedural-based or diagnosis-driven reviews of administrative data. However, patients evaluated by an EGS service may or may not undergo surgery. Therefore, we sought to determine the feasibility of maintaining an EGS registry to include those who do and do not undergo surgery and determine the contribution of nonoperative care to the service.

Methods

Demographic and clinical data for operative and nonoperative general surgery consult patients extracted from the local medical record were entered into a registry over 12 months from 2018 to 2019. We used descriptive statistics to demonstrate differences in demographics and clinical presentation between operative and nonoperative groups.

Results

1065 EGS patients were captured into the registry, only 40 % of whom required an operation. Insurance status and race/ethnicity were different between operative and nonoperative groups. Reasons for consultation varied broadly with the largest group (20 %) being for hepatopancreaticobiliary disease.

Discussion

Providing insight into the important contribution of nonoperative care on EGS burden, we present data from an institutional EGS registry. EGS registries can provide direction for future studies to guide optimal management of EGS patients, especially in resource-limited settings.

Conclusion

Maintaining registries poses challenges but given its importance and the need to determine the contribution of patients who do not undergo procedures to the service load, resources are necessary to ensure they continue.
急诊普通外科(EGS)服务是医院护理的重要组成部分。目前对EGS的审查侧重于基于程序或诊断驱动的行政数据审查。然而,经EGS服务评估的患者可能接受手术,也可能不接受手术。因此,我们试图确定维持EGS登记的可行性,包括那些接受和不接受手术的人,并确定非手术护理对服务的贡献。方法从2018 - 2019年12个月的当地病历中提取手术和非手术普外科会诊患者的人口学和临床资料进行登记。我们使用描述性统计来证明手术组和非手术组在人口统计学和临床表现上的差异。结果共纳入1065例EGS患者,其中40%需要手术治疗。手术组和非手术组的保险状况和种族/民族不同。咨询的原因差异很大,最大的群体(20%)是肝胆胰疾病。为了深入了解非手术护理对EGS负担的重要贡献,我们提供了来自机构EGS登记的数据。EGS登记可以为未来的研究提供方向,以指导EGS患者的最佳管理,特别是在资源有限的情况下。结论维持登记存在挑战,但鉴于其重要性和确定未接受手术的患者对服务负荷的贡献的必要性,需要资源来确保其继续进行。
{"title":"Emergency general surgery: The prevalence of non-operative consultations and importance of a registry","authors":"Nisha Narula ,&nbsp;Shanen M. Mulles ,&nbsp;Aziz M. Merchant ,&nbsp;Kenechi Onwubalili ,&nbsp;Lauren Cue ,&nbsp;Michele Fiorentino ,&nbsp;Nina Awan ,&nbsp;Joseph B. Oliver ,&nbsp;Dustin Cummings ,&nbsp;Michael E. Shapiro ,&nbsp;Anne C. Mosenthal ,&nbsp;David H. Livingston ,&nbsp;Nina E. Glass","doi":"10.1016/j.sipas.2025.100295","DOIUrl":"10.1016/j.sipas.2025.100295","url":null,"abstract":"<div><h3>Introduction</h3><div>An emergency general surgery (EGS) service is a crucial component of care in a hospital. Current reviews of EGS focus on procedural-based or diagnosis-driven reviews of administrative data. However, patients evaluated by an EGS service may or may not undergo surgery. Therefore, we sought to determine the feasibility of maintaining an EGS registry to include those who do and do not undergo surgery and determine the contribution of nonoperative care to the service.</div></div><div><h3>Methods</h3><div>Demographic and clinical data for operative and nonoperative general surgery consult patients extracted from the local medical record were entered into a registry over 12 months from 2018 to 2019. We used descriptive statistics to demonstrate differences in demographics and clinical presentation between operative and nonoperative groups.</div></div><div><h3>Results</h3><div>1065 EGS patients were captured into the registry, only 40 % of whom required an operation. Insurance status and race/ethnicity were different between operative and nonoperative groups. Reasons for consultation varied broadly with the largest group (20 %) being for hepatopancreaticobiliary disease.</div></div><div><h3>Discussion</h3><div>Providing insight into the important contribution of nonoperative care on EGS burden, we present data from an institutional EGS registry. EGS registries can provide direction for future studies to guide optimal management of EGS patients, especially in resource-limited settings.</div></div><div><h3>Conclusion</h3><div>Maintaining registries poses challenges but given its importance and the need to determine the contribution of patients who do not undergo procedures to the service load, resources are necessary to ensure they continue.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100295"},"PeriodicalIF":0.6,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144588484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional and radiological outcomes following sacroiliac screw fixation of posterior pelvic ring injuries: A retrospective study 骶髂螺钉固定骨盆后环损伤后的功能和影像学结果:一项回顾性研究
IF 0.6 Q4 SURGERY Pub Date : 2025-06-30 DOI: 10.1016/j.sipas.2025.100293
Grace EM Kennedy , Ramy Rashed , Joshua Lau , Maham Khan , Mohammad Abdelmonem , Sathya Lakpriya , Bryony Ford , Ahmed El-Bakoury

Background and Aims

Posterior pelvic ring disruption has been associated with high-energy trauma, and significant morbidity and mortality. We aimed to determine functional and radiological outcomes following sacroiliac screw fixation of posterior pelvic ring injuries at a major trauma centre.

Methods

Patients who underwent sacroiliac screw fixation at our institution, between 1st January 2013 – 1st April 2020 were identified from a database. Electronic systems were accessed to obtain information regarding patient demographics, injuries sustained, and interventions performed. Patients were contacted via telephone regarding clinical outcomes (EQ5D3L, EQVAS and Majeed scores). Radiographical outcomes were assessed using the Keshishyan cross-measure method.

Results

115 patients were identified. The mean age at injury was 51.6 years (17–84 years). Most injuries resulted from falls and road traffic collisions (83.5 %). Eighty patients (69.6 %) sustained additional non-pelvic injuries and twenty-nine (25.2 %) underwent a non-pelvic procedure, most commonly limb or clavicle fracture fixation (N = 19). Thirty-day and 12-month all-cause mortality rates were 0.9 % and 1.7 %, respectively. Clinical outcomes were obtained for 82/105 possible patients (78.1 %). Regarding EQ5D3L, 36/82 patients (43.9 %) reported a full health status; only six patients reported severe problems. The mean Majeed score was 70.3. 49/59 patients (86.0 %) returned to their pre-injury employment. A significant association was found between the clinical outcomes (EQ5D3L index, EQVAS, Majeed score) and the pre-operative asymmetry value and deformity index but not the post-operative asymmetry value and deformity index. One patient (0.9 %) required revision for infection, 12 patients (10.4 %) reported post-operative lower limb paraesthesia, and one patient (0.9 %) experienced a post-operative deep vein thrombus.

Conclusions

Most patients with pelvic ring injuries experienced high-energy trauma, often resulting in multiple injuries and operative interventions. Nevertheless, mortality rates were low, and most patients experienced either mild or no functional difficulties. The magnitude of the pelvic deformity pre-operatively correlates with post-operative clinical scores.
背景和目的后骨盆环断裂与高能创伤有关,发病率和死亡率都很高。我们的目的是确定骶骨螺钉固定在主要创伤中心骨盆后环损伤后的功能和影像学结果。方法从数据库中确定2013年1月1日至2020年4月1日在我院接受骶髂螺钉固定的患者。访问电子系统以获取有关患者人口统计、持续伤害和实施干预措施的信息。通过电话联系患者,了解临床结果(EQ5D3L、EQVAS和Majeed评分)。采用Keshishyan交叉测量法评估影像学结果。结果共发现115例患者。平均受伤年龄为51.6岁(17-84岁)。大多数伤害是由跌倒和道路交通碰撞造成的(83.5%)。80例患者(69.6%)持续了额外的非盆腔损伤,29例(25.2%)接受了非盆腔手术,最常见的是肢体或锁骨骨折固定(N = 19)。30天和12个月的全因死亡率分别为0.9%和1.7%。105例可能患者中有82例(78.1%)获得临床结果。对于EQ5D3L, 82例患者中有36例(43.9%)报告完全健康状态;只有6名患者报告了严重的问题。平均Majeed得分为70.3。59例患者中有49例(86.0%)恢复了伤前工作。临床结果(EQ5D3L指数、EQVAS、Majeed评分)与术前不对称值和畸形指数有显著相关性,而与术后不对称值和畸形指数无显著相关性。1例(0.9%)患者因感染需要翻修,12例(10.4%)患者报告术后下肢感觉异常,1例(0.9%)患者出现术后深静脉血栓。结论骨盆环损伤多为高能创伤,多发伤,需手术干预。尽管如此,死亡率很低,大多数患者经历轻微或没有功能困难。术前盆腔畸形的大小与术后临床评分相关。
{"title":"Functional and radiological outcomes following sacroiliac screw fixation of posterior pelvic ring injuries: A retrospective study","authors":"Grace EM Kennedy ,&nbsp;Ramy Rashed ,&nbsp;Joshua Lau ,&nbsp;Maham Khan ,&nbsp;Mohammad Abdelmonem ,&nbsp;Sathya Lakpriya ,&nbsp;Bryony Ford ,&nbsp;Ahmed El-Bakoury","doi":"10.1016/j.sipas.2025.100293","DOIUrl":"10.1016/j.sipas.2025.100293","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Posterior pelvic ring disruption has been associated with high-energy trauma, and significant morbidity and mortality. We aimed to determine functional and radiological outcomes following sacroiliac screw fixation of posterior pelvic ring injuries at a major trauma centre.</div></div><div><h3>Methods</h3><div>Patients who underwent sacroiliac screw fixation at our institution, between 1<sup>st</sup> January 2013 – 1<sup>st</sup> April 2020 were identified from a database. Electronic systems were accessed to obtain information regarding patient demographics, injuries sustained, and interventions performed. Patients were contacted via telephone regarding clinical outcomes (EQ5D3L, EQVAS and Majeed scores). Radiographical outcomes were assessed using the Keshishyan cross-measure method.</div></div><div><h3>Results</h3><div>115 patients were identified. The mean age at injury was 51.6 years (17–84 years). Most injuries resulted from falls and road traffic collisions (83.5 %). Eighty patients (69.6 %) sustained additional non-pelvic injuries and twenty-nine (25.2 %) underwent a non-pelvic procedure, most commonly limb or clavicle fracture fixation (<em>N</em> = 19). Thirty-day and 12-month all-cause mortality rates were 0.9 % and 1.7 %, respectively. Clinical outcomes were obtained for 82/105 possible patients (78.1 %). Regarding EQ5D3L, 36/82 patients (43.9 %) reported a full health status; only six patients reported severe problems. The mean Majeed score was 70.3. 49/59 patients (86.0 %) returned to their pre-injury employment. A significant association was found between the clinical outcomes (EQ5D3L index, EQVAS, Majeed score) and the pre-operative asymmetry value and deformity index but not the post-operative asymmetry value and deformity index. One patient (0.9 %) required revision for infection, 12 patients (10.4 %) reported post-operative lower limb paraesthesia, and one patient (0.9 %) experienced a post-operative deep vein thrombus.</div></div><div><h3>Conclusions</h3><div>Most patients with pelvic ring injuries experienced high-energy trauma, often resulting in multiple injuries and operative interventions. Nevertheless, mortality rates were low, and most patients experienced either mild or no functional difficulties. The magnitude of the pelvic deformity pre-operatively correlates with post-operative clinical scores.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100293"},"PeriodicalIF":0.6,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144605309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversal of Hartmann’s procedure: The impact of timing – a single-tertiary-center experience 哈特曼程序的逆转:时间的影响-单一三中心的经验
IF 0.6 Q4 SURGERY Pub Date : 2025-06-15 DOI: 10.1016/j.sipas.2025.100292
Sascha Vaghiri , Maria Chara Stylianidi , Laura Engelmann , Eslam Elmaghraby , Levent Dizdar , Wolfram Trudo Knoefel , Hermann Kessler , Dimitrios Prassas

Introduction

The optimal timing for Hartmann’s reversal remains a topic of ongoing debate. This study aimed to assess postoperative outcomes in patients undergoing early versus late Hartmann’s reversal at a tertiary academic center in Germany.

Methods

A single-center retrospective cohort study was conducted, including all patients who underwent Hartmann’s reversal between January 2008 and July 2020. Patients were stratified into early (ER) and late (LR) reversal groups using a median cut-off value of 159 days. Operative outcomes including major morbidity and overall postoperative complications were compared between both groups. Factors associated with major postoperative morbidity were detected using uni- and multivariate regression models.

Results

A total of 133 patients classified into the ER (n = 67, 50.38%) and LR (n = 66, 49.62%) groups were analyzed. There were no significant differences in overall morbidity (ER 56.72% versus LR 39.39%, p = 0.057) and major morbidity rates (Clavien-Dindo ≥ IIIa) (ER 28.36% versus LR 21.21%, p = 0.423) between both groups. On multivariate analysis, smoking (p = 0.006), chronic renal disease (p = 0.003) and anastomotic configuration (p = 0.003) were identified as significant factors contributing to major morbidity after Hartmann’s reversal.

Conclusion

Hartmann’s reversal is still associated with an increased risk of postoperative complications. However, timing of Hartmann’s reversal does not seem to influence postoperative morbidity. Of note, patient-related modifiable factors as well as the anastomotic configuration are important determinants of major complication occurrence.
哈特曼逆转的最佳时机仍然是一个持续争论的话题。本研究旨在评估德国某高等学术中心早期和晚期哈特曼逆转患者的术后结果。方法采用单中心回顾性队列研究,纳入2008年1月至2020年7月期间接受哈特曼逆转的所有患者。采用159天的中位临界值将患者分为早期(ER)和晚期(LR)逆转组。比较两组的手术结果,包括主要发病率和术后总并发症。使用单因素和多因素回归模型检测与主要术后发病率相关的因素。结果133例患者分为ER组(n = 67, 50.38%)和LR组(n = 66, 49.62%)。两组总发病率(ER为56.72%,LR为39.39%,p = 0.057)和主要发病率(Clavien-Dindo≥IIIa) (ER为28.36%,LR为21.21%,p = 0.423)差异无统计学意义。在多因素分析中,吸烟(p = 0.006)、慢性肾脏疾病(p = 0.003)和吻合口形态(p = 0.003)被确定为Hartmann逆转后主要发病率的重要因素。结论hartmann反转仍与术后并发症风险增加有关。然而,Hartmann逆转的时机似乎并不影响术后发病率。值得注意的是,患者相关的可改变因素以及吻合口结构是主要并发症发生的重要决定因素。
{"title":"Reversal of Hartmann’s procedure: The impact of timing – a single-tertiary-center experience","authors":"Sascha Vaghiri ,&nbsp;Maria Chara Stylianidi ,&nbsp;Laura Engelmann ,&nbsp;Eslam Elmaghraby ,&nbsp;Levent Dizdar ,&nbsp;Wolfram Trudo Knoefel ,&nbsp;Hermann Kessler ,&nbsp;Dimitrios Prassas","doi":"10.1016/j.sipas.2025.100292","DOIUrl":"10.1016/j.sipas.2025.100292","url":null,"abstract":"<div><h3>Introduction</h3><div>The optimal timing for Hartmann’s reversal remains a topic of ongoing debate. This study aimed to assess postoperative outcomes in patients undergoing early versus late Hartmann’s reversal at a tertiary academic center in Germany.</div></div><div><h3>Methods</h3><div>A single-center retrospective cohort study was conducted, including all patients who underwent Hartmann’s reversal between January 2008 and July 2020. Patients were stratified into early (ER) and late (LR) reversal groups using a median cut-off value of 159 days. Operative outcomes including major morbidity and overall postoperative complications were compared between both groups. Factors associated with major postoperative morbidity were detected using uni- and multivariate regression models.</div></div><div><h3>Results</h3><div>A total of 133 patients classified into the ER (n = 67, 50.38%) and LR (n = 66, 49.62%) groups were analyzed. There were no significant differences in overall morbidity (ER 56.72% versus LR 39.39%, p = 0.057) and major morbidity rates (Clavien-Dindo ≥ IIIa) (ER 28.36% versus LR 21.21%, p = 0.423) between both groups. On multivariate analysis, smoking (p = 0.006), chronic renal disease (p = 0.003) and anastomotic configuration (p = 0.003) were identified as significant factors contributing to major morbidity after Hartmann’s reversal.</div></div><div><h3>Conclusion</h3><div>Hartmann’s reversal is still associated with an increased risk of postoperative complications. However, timing of Hartmann’s reversal does not seem to influence postoperative morbidity. Of note, patient-related modifiable factors as well as the anastomotic configuration are important determinants of major complication occurrence.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100292"},"PeriodicalIF":0.6,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144321728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in surgical care for low- and middle-income countries: Challenges, opportunities, and the path forward 低收入和中等收入国家外科护理中的人工智能:挑战、机遇和前进道路
IF 0.6 Q4 SURGERY Pub Date : 2025-06-06 DOI: 10.1016/j.sipas.2025.100290
William Nkenguye
The application of Artificial Intelligence (AI) and Machine Learning (ML) in surgical care has significantly advanced healthcare delivery in high-income countries (HICs), yet remains underutilized in lower- and middle-income countries (LMICs). With a growing burden of surgical diseases, limited surgical expertise, and constrained healthcare resources, AI and ML offer transformative potential in optimizing surgical workflows, improving patient outcomes, and expanding access to specialized care. This manuscript explores the current status, challenges, and future prospects of AI and ML in surgical care for LMICs, emphasizing the critical need for investment, capacity building, and policy development to bridge the healthcare gap.
人工智能(AI)和机器学习(ML)在外科护理中的应用显著提高了高收入国家(HICs)的医疗保健服务水平,但在中低收入国家(LMICs)仍未得到充分利用。随着外科疾病负担的增加、外科专业知识的有限和医疗保健资源的限制,人工智能和机器学习在优化外科工作流程、改善患者预后和扩大专业护理机会方面提供了变革性潜力。本文探讨了人工智能和机器学习在中低收入国家外科护理中的现状、挑战和未来前景,强调了对投资、能力建设和政策制定的迫切需要,以弥合医疗保健差距。
{"title":"Artificial intelligence in surgical care for low- and middle-income countries: Challenges, opportunities, and the path forward","authors":"William Nkenguye","doi":"10.1016/j.sipas.2025.100290","DOIUrl":"10.1016/j.sipas.2025.100290","url":null,"abstract":"<div><div>The application of Artificial Intelligence (AI) and Machine Learning (ML) in surgical care has significantly advanced healthcare delivery in high-income countries (HICs), yet remains underutilized in lower- and middle-income countries (LMICs). With a growing burden of surgical diseases, limited surgical expertise, and constrained healthcare resources, AI and ML offer transformative potential in optimizing surgical workflows, improving patient outcomes, and expanding access to specialized care. This manuscript explores the current status, challenges, and future prospects of AI and ML in surgical care for LMICs, emphasizing the critical need for investment, capacity building, and policy development to bridge the healthcare gap.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100290"},"PeriodicalIF":0.6,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144291439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synchronous adenocarcinoma of the transverse colon and gastroesophageal junction: a case report 横结肠胃食管交界处同步腺癌1例
IF 0.6 Q4 SURGERY Pub Date : 2025-06-04 DOI: 10.1016/j.sipas.2025.100289
Adam Avas , Astrid Schümatschek , Julia Mühlhäusser , Martin Bolli , Markus Gass , Francesco Mongelli

Introduction

Esophageal cancer is a malignancy with a rapidly increasing incidence in recent decades. The presence of a second synchronous tumor poses challenges when a curative approach is offered.

Case presentation

We report a case of a 68-year-old Caucasian male diagnosed with synchronous adenocarcinomas of the transverse colon and the gastroesophageal junction (GEJ), Siewert Type II. The diagnosis followed the presentation of dysphagia and was confirmed through esophagogastroduodenoscopy and colonoscopy. The patient underwent a staging work-up. This has revealed no distant metastases, leading to a decision for curative treatment with multimodal therapy. Neoadjuvant chemotherapy with the FLOT regimen was administered, followed by thoracoabdominal esophagectomy and extended right hemicolectomy. Histopathological and molecular profiling analyses revealed that the tumor of the colon was a metastasis of the GEJ tumor.

Clinical discussion

This case demonstrates the diagnostic and therapeutic challenges posed by rare metastatic pattern of the GEJ. Despite thorough preoperative staging, the metastatic nature of the colonic lesion was only revealed postoperatively in our case. This emphasizes the need for molecular profiling in selected cases to enhance diagnostic accuracy and guide treatment decisions more effectively.

Conclusion

Colonic metastases from esophageal cancer are exceedingly rare, with only a few cases reported. In this case, according to the postoperative staging (M1) a palliative chemotherapy might have been more appropriate. This case highlights the importance of comprehensive diagnostic workups and the need for molecular profiling of synchronous lesions. Molecular diagnostic may be considered as a part of decision-making, as it can significantly impact treatment strategies and outcomes.
食管癌是近几十年来发病率迅速上升的一种恶性肿瘤。当提供治疗方法时,第二同步肿瘤的存在提出了挑战。我们报告一例68岁的白人男性被诊断为横结肠和胃食管交界处(GEJ)的同步腺癌,Siewert II型。在出现吞咽困难后诊断,并通过食管胃十二指肠镜和结肠镜检查证实。病人接受了分期检查。这表明没有远处转移,因此决定采用多模式治疗。给予FLOT方案的新辅助化疗,随后进行胸腹食管切除术和扩大的右半结肠切除术。组织病理学和分子分析表明,结肠肿瘤是GEJ肿瘤的转移灶。本病例展示了罕见的GEJ转移模式所带来的诊断和治疗挑战。尽管术前进行了彻底的分期,但在我们的病例中,结肠病变的转移性仅在术后才被发现。这强调了在选定病例中进行分子谱分析以提高诊断准确性和更有效地指导治疗决策的必要性。结论食管癌结肠转移极为罕见,文献报道较少。在这种情况下,根据术后分期(M1),姑息性化疗可能更合适。该病例强调了综合诊断检查的重要性和同步病变分子谱分析的必要性。分子诊断可以被认为是决策的一部分,因为它可以显著影响治疗策略和结果。
{"title":"Synchronous adenocarcinoma of the transverse colon and gastroesophageal junction: a case report","authors":"Adam Avas ,&nbsp;Astrid Schümatschek ,&nbsp;Julia Mühlhäusser ,&nbsp;Martin Bolli ,&nbsp;Markus Gass ,&nbsp;Francesco Mongelli","doi":"10.1016/j.sipas.2025.100289","DOIUrl":"10.1016/j.sipas.2025.100289","url":null,"abstract":"<div><h3>Introduction</h3><div>Esophageal cancer is a malignancy with a rapidly increasing incidence in recent decades. The presence of a second synchronous tumor poses challenges when a curative approach is offered.</div></div><div><h3>Case presentation</h3><div>We report a case of a 68-year-old Caucasian male diagnosed with synchronous adenocarcinomas of the transverse colon and the gastroesophageal junction (GEJ), Siewert Type II. The diagnosis followed the presentation of dysphagia and was confirmed through esophagogastroduodenoscopy and colonoscopy. The patient underwent a staging work-up. This has revealed no distant metastases, leading to a decision for curative treatment with multimodal therapy. Neoadjuvant chemotherapy with the FLOT regimen was administered, followed by thoracoabdominal esophagectomy and extended right hemicolectomy. Histopathological and molecular profiling analyses revealed that the tumor of the colon was a metastasis of the GEJ tumor.</div></div><div><h3>Clinical discussion</h3><div>This case demonstrates the diagnostic and therapeutic challenges posed by rare metastatic pattern of the GEJ. Despite thorough preoperative staging, the metastatic nature of the colonic lesion was only revealed postoperatively in our case. This emphasizes the need for molecular profiling in selected cases to enhance diagnostic accuracy and guide treatment decisions more effectively.</div></div><div><h3>Conclusion</h3><div>Colonic metastases from esophageal cancer are exceedingly rare, with only a few cases reported. In this case, according to the postoperative staging (M1) a palliative chemotherapy might have been more appropriate. This case highlights the importance of comprehensive diagnostic workups and the need for molecular profiling of synchronous lesions. Molecular diagnostic may be considered as a part of decision-making, as it can significantly impact treatment strategies and outcomes.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100289"},"PeriodicalIF":0.6,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144263537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal cancer surgery in Ethiopia: postoperative mortality and long-term survival 埃塞俄比亚食管癌手术:术后死亡率和长期生存率
IF 0.6 Q4 SURGERY Pub Date : 2025-06-03 DOI: 10.1016/j.sipas.2025.100288
Mintesinot Birhanu Senbeta , Sileshi Abiy , Hirbo Samuel , Nigist Birhanu

Introduction

Cancer remains the leading cause of death worldwide, with esophageal cancer being the sixth leading cause of cancer-related deaths. For individuals with esophageal cancer, esophagectomy is the most effective treatment option available and has a high risk of both death and morbidity. Moreover, despite advances in preoperative optimization, surgery, and anesthesia techniques as well as the introduction of neoadjuvant therapy, the mortality and morbidity associated with esophagectomy remain high.

Objective

To assess the survival status and predictors of postoperative survival in patients who underwent esophageal surgery for esophageal malignancies at selected hospitals from to 2018–2023 in Ethiopia, Addis Ababa.

Methods

This was a retrospective cohort study. After acquiring data from the chart review, the data were analyzed using R version 4.3.3. Descriptive statistics for categorical variables were reported as frequencies and percentages. Kaplan-Meier curves and log-rank tests were used to estimate the survival curve and the difference in survival among groups within each covariate. After esophageal surgery, the impact of each covariate on time to death was assessed using the Cox proportional hazard model.

Results

One hundred eighty-three patients who underwent esophageal surgeries for esophageal malignancy at four governmental hospitals in Addis Ababa over 5 years were included. The mean age was 53.8 years. 120 (65.6 %) had a tumor size <3.3 cm, and squamous cell carcinoma accounted for 154 (84.2 %) cases. Epidural analgesia was the most commonly used analgesic technique, 40 (21.9 %). The 30-day mortality was 10.9 %. The overall 1-, 2-, 3-, 4-, and 5-year survival rates were 53 %, 30.6 %, 19.5 %, 19.5 %, and 13 %, respectively. The median survival was 17 months. ASA score of > III (AHR = 2.14, 95 % CI: 1.12–4.12), cervical anastomotic leak (AHR = 3.29, 95 % CI: 1.44–7.52), and sepsis (AHR = 3.70, 95 % CI: 1.46–9.38) were identified as predictors of postoperative mortality in the multivariate Cox regression model.

Conclusion

In Ethiopia, patients who underwent surgery for esophageal cancer had low 5-year survival rates.
癌症仍然是全球死亡的主要原因,食道癌是癌症相关死亡的第六大原因。对于食管癌患者,食管癌切除术是最有效的治疗选择,但其死亡率和发病率都很高。此外,尽管术前优化、手术和麻醉技术以及新辅助治疗的引入取得了进展,但与食管切除术相关的死亡率和发病率仍然很高。目的评估2018-2023年埃塞俄比亚亚的斯亚贝巴选定医院食道恶性肿瘤手术患者的生存状况及术后生存预测因素。方法回顾性队列研究。从图表评审中获取数据后,使用R 4.3.3版本对数据进行分析。分类变量的描述性统计以频率和百分比报告。Kaplan-Meier曲线和log-rank检验用于估计每个协变量内组间的生存曲线和生存差异。食道手术后,使用Cox比例风险模型评估每个协变量对死亡时间的影响。结果5年内在亚的斯亚贝巴4家政府医院行食管恶性肿瘤手术的患者183例。平均年龄为53.8岁。肿瘤大小3.3 cm 120例(65.6%),鳞状细胞癌154例(84.2%)。硬膜外镇痛是最常用的镇痛技术,占21.9%。30天死亡率为10.9%。总体1、2、3、4和5年生存率分别为53%、30.6%、19.5%、19.5%和13%。中位生存期为17个月。ASA评分>;在多因素Cox回归模型中,III期(AHR = 2.14, 95% CI: 1.12-4.12)、颈吻合口漏(AHR = 3.29, 95% CI: 1.44-7.52)和脓毒症(AHR = 3.70, 95% CI: 1.46-9.38)被确定为术后死亡率的预测因素。结论在埃塞俄比亚,食管癌手术患者5年生存率较低。
{"title":"Esophageal cancer surgery in Ethiopia: postoperative mortality and long-term survival","authors":"Mintesinot Birhanu Senbeta ,&nbsp;Sileshi Abiy ,&nbsp;Hirbo Samuel ,&nbsp;Nigist Birhanu","doi":"10.1016/j.sipas.2025.100288","DOIUrl":"10.1016/j.sipas.2025.100288","url":null,"abstract":"<div><h3>Introduction</h3><div>Cancer remains the leading cause of death worldwide, with esophageal cancer being the sixth leading cause of cancer-related deaths. For individuals with esophageal cancer, esophagectomy is the most effective treatment option available and has a high risk of both death and morbidity. Moreover, despite advances in preoperative optimization, surgery, and anesthesia techniques as well as the introduction of neoadjuvant therapy, the mortality and morbidity associated with esophagectomy remain high.</div></div><div><h3>Objective</h3><div>To assess the survival status and predictors of postoperative survival in patients who underwent esophageal surgery for esophageal malignancies at selected hospitals from to 2018–2023 in Ethiopia, Addis Ababa.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study. After acquiring data from the chart review, the data were analyzed using R version 4.3.3. Descriptive statistics for categorical variables were reported as frequencies and percentages. Kaplan-Meier curves and log-rank tests were used to estimate the survival curve and the difference in survival among groups within each covariate. After esophageal surgery, the impact of each covariate on time to death was assessed using the Cox proportional hazard model.</div></div><div><h3>Results</h3><div>One hundred eighty-three patients who underwent esophageal surgeries for esophageal malignancy at four governmental hospitals in Addis Ababa over 5 years were included. The mean age was 53.8 years. 120 (65.6 %) had a tumor size &lt;3.3 cm, and squamous cell carcinoma accounted for 154 (84.2 %) cases. Epidural analgesia was the most commonly used analgesic technique, 40 (21.9 %). The 30-day mortality was 10.9 %. The overall 1-, 2-, 3-, 4-, and 5-year survival rates were 53 %, 30.6 %, 19.5 %, 19.5 %, and 13 %, respectively. The median survival was 17 months. ASA score of &gt; III (AHR = 2.14, 95 % CI: 1.12–4.12), cervical anastomotic leak (AHR = 3.29, 95 % CI: 1.44–7.52), and sepsis (AHR = 3.70, 95 % CI: 1.46–9.38) were identified as predictors of postoperative mortality in the multivariate Cox regression model.</div></div><div><h3>Conclusion</h3><div>In Ethiopia, patients who underwent surgery for esophageal cancer had low 5-year survival rates.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"22 ","pages":"Article 100288"},"PeriodicalIF":0.6,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144253685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of verapamil on intestinal injury in a rat model of acute mesenteric ischemia 维拉帕米对急性肠系膜缺血大鼠肠道损伤的影响
IF 0.6 Q4 SURGERY Pub Date : 2025-06-01 DOI: 10.1016/j.sipas.2025.100286
Silvana N Wilken , Diego V Santos Rodrigues , Colin Price , Julia Jacobs , Jack Nelson , Patrick F Walker , Jonathan J Morrison

Background

Acute mesenteric ischemia (AMI) is a surgical emergency requiring prompt revascularization with resection of unsalvageable bowel. Despite successful revascularization, ongoing organ damage can persist from ischemia-reperfusion injury (IRI) and there is a need for adjunct therapies to ameliorate this ongoing insult.

Materials and methods

Sprague-Dawley rats (n = 36) were divided into five groups: control, heparin (HEP), HEP + verapamil (VER), HEP + valproic acid (VPA), HEP+VER+VPA. The animals were subjected to 45 min of superior mesenteric artery occlusion followed by 4 h of reperfusion. Upon reperfusion, therapies were administered. Plasma samples were collected before occlusion and at end-of-study for intestinal fatty acid binding protein (I-FABP) and pro-inflammatory cytokines. The full length of the small intestine was collected, stained with H&E and scored according to the Park/Chiu score for intestinal ischemia damage.

Results

Twenty-three of 36 rats survived 4 h of reperfusion and there was no difference in survival between the groups. I-FABP levels was significantly lower in HEP+VER vs. control (3.8 ± 1.5 vs. 6.18 ± 1.0ng/ml; p = 0.0040). IL-1beta, IL-6 and TNF-alpha showed the lowest mean values in the HEP+VER group compared to all groups. The histological analysis revealed the lowest score of intestinal damage in the HEP+VER group, however, the difference to control was not significant.

Conclusion

Administering heparin and verapamil at the time of revascularization may mitigate intestinal IRI without causing detrimental systemic effects. Further studies in large animal models and in the setting of local administration are needed to investigate the potential of this approach.
背景:急性肠系膜缺血(AMI)是一种外科急症,需要及时行血运重建并切除无法挽救的肠。尽管成功的血运重建,持续的器官损伤可能持续缺血再灌注损伤(IRI),需要辅助治疗来改善这种持续的损害。材料与方法36只sd大鼠分为5组:对照组、肝素组(HEP)、HEP+维拉帕米组(VER)、HEP+丙戊酸组(VPA)、HEP+VER+VPA。动物进行肠系膜上动脉阻断45分钟,再灌注4小时。再灌注后给予治疗。在闭塞前和研究结束时收集血浆样本,检测肠脂肪酸结合蛋白(I-FABP)和促炎细胞因子。取小肠全长,进行H&;E染色,按照Park/Chiu评分进行肠缺血损伤评分。结果36只大鼠再灌注4 h后存活23只,各组间生存率无差异。HEP+VER组I-FABP水平明显低于对照组(3.8±1.5 vs 6.18±1.0ng/ml;P = 0.0040)。与所有组相比,HEP+VER组il -1 β、IL-6和tnf - α的平均值最低。组织学分析显示,HEP+VER组肠道损伤评分最低,但与对照组差异不显著。结论肝素和维拉帕米在血运重建术时可减轻肠IRI,且对全身无不良影响。需要在大型动物模型和地方管理环境中进行进一步研究,以调查这种方法的潜力。
{"title":"Effects of verapamil on intestinal injury in a rat model of acute mesenteric ischemia","authors":"Silvana N Wilken ,&nbsp;Diego V Santos Rodrigues ,&nbsp;Colin Price ,&nbsp;Julia Jacobs ,&nbsp;Jack Nelson ,&nbsp;Patrick F Walker ,&nbsp;Jonathan J Morrison","doi":"10.1016/j.sipas.2025.100286","DOIUrl":"10.1016/j.sipas.2025.100286","url":null,"abstract":"<div><h3>Background</h3><div>Acute mesenteric ischemia (AMI) is a surgical emergency requiring prompt revascularization with resection of unsalvageable bowel. Despite successful revascularization, ongoing organ damage can persist from ischemia-reperfusion injury (IRI) and there is a need for adjunct therapies to ameliorate this ongoing insult.</div></div><div><h3>Materials and methods</h3><div>Sprague-Dawley rats (<em>n</em> = 36) were divided into five groups: control, heparin (HEP), HEP + verapamil (VER), HEP + valproic acid (VPA), HEP+VER+VPA. The animals were subjected to 45 min of superior mesenteric artery occlusion followed by 4 h of reperfusion. Upon reperfusion, therapies were administered. Plasma samples were collected before occlusion and at end-of-study for intestinal fatty acid binding protein (I-FABP) and pro-inflammatory cytokines. The full length of the small intestine was collected, stained with H&amp;E and scored according to the Park/Chiu score for intestinal ischemia damage.</div></div><div><h3>Results</h3><div>Twenty-three of 36 rats survived 4 h of reperfusion and there was no difference in survival between the groups. I-FABP levels was significantly lower in HEP+VER vs. control (3.8 ± 1.5 vs. 6.18 ± 1.0ng/ml; <em>p</em> = 0.0040). IL-1beta, IL-6 and TNF-alpha showed the lowest mean values in the HEP+VER group compared to all groups. The histological analysis revealed the lowest score of intestinal damage in the HEP+VER group, however, the difference to control was not significant.</div></div><div><h3>Conclusion</h3><div>Administering heparin and verapamil at the time of revascularization may mitigate intestinal IRI without causing detrimental systemic effects. Further studies in large animal models and in the setting of local administration are needed to investigate the potential of this approach.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"21 ","pages":"Article 100286"},"PeriodicalIF":0.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144230178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of Gastric Cancer Lymph Nodes Based on Groups, Regions, and Stages 基于分组、区域和分期的胃癌淋巴结回顾性分析
IF 0.6 Q4 SURGERY Pub Date : 2025-06-01 DOI: 10.1016/j.sipas.2025.100287
Si-kai Song , Jiang Zhu , Hai-min Feng , An-she Ma , Chao-gang Yang

Objective

The consistency between clinical and pathological staging of lymph nodes (LNs) in gastric cancer (GC) remains suboptimal, and there is currently no standardized imaging criterion for diagnosing lymph node metastasis (LNM). This study aimed to elucidate the differences in LNs among various groups, regions, and stages, utilizing imaging and histopathology as the foundational basis.

Methods

We retrospectively analyzed the clinical data of 100 GC patients who underwent surgical treatment at Zhongnan Hospital of Wuhan University between January 2022 and May 2023. Patient characteristics, along with pathological and radiological data of LNs, were collected and compared across different groups, regions, and stages.

Results

Pathologically, 3566 LNs were collected, with a median of 35 (range: 17–72). Radiologically, 2233 LNs were collected, with a median of 22 (range: 3–47). Significant differences were observed in the long-axis diameter (LAD), short-axis diameter (SAD), ratios of long to short axis (RLSA), and product of long and short axis (PLSA) between negative and positive LNs. However, only within group 3 did the RLSA show statistical significance upon grouping analysis. The areas under the curve (AUC) for LAD, SAD, PLSA, and their combination index (CI) in diagnosing LNM were 0.817, 0.817, 0.828, and 0.827, respectively. Diverse groups, regions, and stages exerted a more pronounced influence on LN groups 1–6, while having a comparatively lesser impact on LN groups 7–16.

Conclusion

LAD, SAD, and PLSA exhibited significant diagnostic value for LNM and could serve as diagnostic criteria; however, RLSA demonstrated limited diagnostic utility. The formulation of diagnostic criteria should consider the impact of groups, regions, and stages to enhance sensitivity and specificity.
目的胃癌(GC)淋巴结临床分期与病理分期的一致性尚不理想,目前尚无标准化的淋巴结转移诊断影像学标准。本研究旨在利用影像学和组织病理学作为基础,阐明不同群体、不同区域和不同分期的ln差异。方法回顾性分析2022年1月至2023年5月武汉大学中南医院手术治疗的100例胃癌患者的临床资料。收集不同组、地区和分期的患者特征、病理和放射学资料,并进行比较。结果病理共收集病灶3566例,中位数35例(范围17 ~ 72)。放射学上,收集了2233例LNs,中位数为22(范围:3-47)。阴性LNs与阳性LNs的长轴直径(LAD)、短轴直径(SAD)、长轴与短轴之比(RLSA)、长轴与短轴之积(PLSA)均有显著差异。但分组分析时,RLSA只有在第3组中才有统计学意义。LAD、SAD、PLSA诊断LNM的曲线下面积(AUC)及其联合指数(CI)分别为0.817、0.817、0.828、0.827。不同的群体、地区和阶段对LN 1-6组的影响更为明显,而对LN 7-16组的影响相对较小。结论lad、SAD、PLSA对LNM具有较强的诊断价值,可作为LNM的诊断标准;然而,RLSA的诊断作用有限。诊断标准的制定应考虑群体、地区和分期的影响,以提高敏感性和特异性。
{"title":"A retrospective analysis of Gastric Cancer Lymph Nodes Based on Groups, Regions, and Stages","authors":"Si-kai Song ,&nbsp;Jiang Zhu ,&nbsp;Hai-min Feng ,&nbsp;An-she Ma ,&nbsp;Chao-gang Yang","doi":"10.1016/j.sipas.2025.100287","DOIUrl":"10.1016/j.sipas.2025.100287","url":null,"abstract":"<div><h3>Objective</h3><div>The consistency between clinical and pathological staging of lymph nodes (LNs) in gastric cancer (GC) remains suboptimal, and there is currently no standardized imaging criterion for diagnosing lymph node metastasis (LNM). This study aimed to elucidate the differences in LNs among various groups, regions, and stages, utilizing imaging and histopathology as the foundational basis.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed the clinical data of 100 GC patients who underwent surgical treatment at Zhongnan Hospital of Wuhan University between January 2022 and May 2023. Patient characteristics, along with pathological and radiological data of LNs, were collected and compared across different groups, regions, and stages.</div></div><div><h3>Results</h3><div>Pathologically, 3566 LNs were collected, with a median of 35 (range: 17–72). Radiologically, 2233 LNs were collected, with a median of 22 (range: 3–47). Significant differences were observed in the long-axis diameter (LAD), short-axis diameter (SAD), ratios of long to short axis (RLSA), and product of long and short axis (PLSA) between negative and positive LNs. However, only within group 3 did the RLSA show statistical significance upon grouping analysis. The areas under the curve (AUC) for LAD, SAD, PLSA, and their combination index (CI) in diagnosing LNM were 0.817, 0.817, 0.828, and 0.827, respectively. Diverse groups, regions, and stages exerted a more pronounced influence on LN groups 1–6, while having a comparatively lesser impact on LN groups 7–16.</div></div><div><h3>Conclusion</h3><div>LAD, SAD, and PLSA exhibited significant diagnostic value for LNM and could serve as diagnostic criteria; however, RLSA demonstrated limited diagnostic utility. The formulation of diagnostic criteria should consider the impact of groups, regions, and stages to enhance sensitivity and specificity.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"21 ","pages":"Article 100287"},"PeriodicalIF":0.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144204838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventral hernia repair with T-line hernia mesh: A multi-institutional experience 用t线疝补片修补腹疝:一个多机构的经验
IF 0.6 Q4 SURGERY Pub Date : 2025-05-12 DOI: 10.1016/j.sipas.2025.100285
Emmanuel O. Emovon III , Anna Malysz Oyola , Luis Arias-Espinosa , Hani I. Naga , Angela S. Volk , William Hope , Flavio Malcher , Jamie P. Levine , Hobart W. Harris , Jin Yoo , Ash Patel

Introduction

Ventral hernia repair (VHR) is a common procedure complicated by high hernia recurrence rates exceeding 30 % over ten years. The T-Line® Hernia Mesh is a synthetic, polypropylene mesh featuring mesh extensions designed to prevent anchor point failure by evenly distributing tension to reduce ventral hernia recurrences. This study evaluates the outcomes of the T-Line® mesh in VHR with 1–3 year follow-up.

Methods

This study is a multi-institutional retrospective cohort study on patients who underwent VHR with T-Line® mesh between October 2020 and December 2022. Patient demographics, surgical details, and postoperative outcomes were collected. Patient-reported outcomes were assessed using HerQLes and ACHQC surveys.

Results

Fifty-seven patients underwent VHR with the T-Line® mesh with a median age of sixty years and BMI of 30.8 kg/m2. The median follow-up was 454 days with a range of 365 to 1192 days. The median defect area was 97.0 cm2 and mesh area was 300 cm2. Seventeen patients (29.8 %) underwent hernia repair with panniculectomy. Postoperatively, seven patients (12.3 %) presented to the emergency department within 30 days, with five patients (8.8 %) requiring readmission. Eight patients (14.0 %) experienced complications within thirty days, with the majority being surgical site infections (n = 7, 12.3 %). Of the five patients that reported feeling a slight bulge at their previous hernia site, upon clinical evaluation two patients had a recurrence (one recurrence was caused by the suture tearing through the underlying laparotomy repair while the mesh remained anchored intact above the repair, and the second recurrence was caused by inadequate mesh fixation at the caudal border of the mesh), while no patients reported using pain medication for abdominal wall discomfort.

Conclusions

The T-Line® Hernia Mesh demonstrated safety and effectiveness in ventral hernia repair, with low recurrences and postoperative complications rates over a 1–3-year period, suggesting it is a valuable tool for complex hernia repairs.
腹疝修补术(VHR)是一种常见的手术,十年来疝复发率超过30%。T-Line®疝补片是一种合成聚丙烯补片,具有补片扩展功能,旨在通过均匀分布张力来防止锚点失效,以减少腹侧疝复发。本研究通过1-3年随访评估T-Line®补片治疗VHR的效果。方法本研究是一项多机构回顾性队列研究,研究对象是2020年10月至2022年12月期间使用T-Line®补片进行VHR的患者。收集患者人口统计资料、手术细节和术后结果。采用HerQLes和ACHQC调查评估患者报告的结果。结果57例患者采用T-Line®补片行VHR,中位年龄60岁,BMI为30.8 kg/m2。中位随访为454天,范围为365天至1192天。中位缺损面积97.0 cm2,网状面积300 cm2。17例(29.8%)患者行疝修补术合并胰管切除术。术后,7例(12.3%)患者在30天内到急诊科就诊,5例(8.8%)患者需要再次入院。8例患者(14.0%)在30天内出现并发症,其中大多数为手术部位感染(n = 7, 12.3%)。5例患者报告在先前的疝部位有轻微隆起感,经临床评估,2例患者复发(1例复发是由于缝线在剖腹修补术中撕裂,而补片在修补术上方锚固完好,2例复发是由于补片尾缘固定不充分引起的),而没有患者报告使用止痛药治疗腹壁不适。结论T-Line®疝补片在腹侧疝修补中具有安全性和有效性,在1 - 3年期间复发率低,术后并发症发生率低,是一种有价值的复杂疝修补工具。
{"title":"Ventral hernia repair with T-line hernia mesh: A multi-institutional experience","authors":"Emmanuel O. Emovon III ,&nbsp;Anna Malysz Oyola ,&nbsp;Luis Arias-Espinosa ,&nbsp;Hani I. Naga ,&nbsp;Angela S. Volk ,&nbsp;William Hope ,&nbsp;Flavio Malcher ,&nbsp;Jamie P. Levine ,&nbsp;Hobart W. Harris ,&nbsp;Jin Yoo ,&nbsp;Ash Patel","doi":"10.1016/j.sipas.2025.100285","DOIUrl":"10.1016/j.sipas.2025.100285","url":null,"abstract":"<div><h3>Introduction</h3><div>Ventral hernia repair (VHR) is a common procedure complicated by high hernia recurrence rates exceeding 30 % over ten years. The T-Line® Hernia Mesh is a synthetic, polypropylene mesh featuring mesh extensions designed to prevent anchor point failure by evenly distributing tension to reduce ventral hernia recurrences. This study evaluates the outcomes of the T-Line® mesh in VHR with 1–3 year follow-up.</div></div><div><h3>Methods</h3><div>This study is a multi-institutional retrospective cohort study on patients who underwent VHR with T-Line® mesh between October 2020 and December 2022. Patient demographics, surgical details, and postoperative outcomes were collected. Patient-reported outcomes were assessed using HerQLes and ACHQC surveys.</div></div><div><h3>Results</h3><div>Fifty-seven patients underwent VHR with the T-Line® mesh with a median age of sixty years and BMI of 30.8 kg/m<sup>2</sup>. The median follow-up was 454 days with a range of 365 to 1192 days. The median defect area was 97.0 cm<sup>2</sup> and mesh area was 300 cm<sup>2</sup>. Seventeen patients (29.8 %) underwent hernia repair with panniculectomy. Postoperatively, seven patients (12.3 %) presented to the emergency department within 30 days, with five patients (8.8 %) requiring readmission. Eight patients (14.0 %) experienced complications within thirty days, with the majority being surgical site infections (<em>n</em> = 7, 12.3 %). Of the five patients that reported feeling a slight bulge at their previous hernia site, upon clinical evaluation two patients had a recurrence (one recurrence was caused by the suture tearing through the underlying laparotomy repair while the mesh remained anchored intact above the repair, and the second recurrence was caused by inadequate mesh fixation at the caudal border of the mesh), while no patients reported using pain medication for abdominal wall discomfort.</div></div><div><h3>Conclusions</h3><div>The T-Line® Hernia Mesh demonstrated safety and effectiveness in ventral hernia repair, with low recurrences and postoperative complications rates over a 1–3-year period, suggesting it is a valuable tool for complex hernia repairs.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"21 ","pages":"Article 100285"},"PeriodicalIF":0.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery in practice and science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1